×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| DIPNA PHARMACHEM LIMITED | NA | NA | NA | NA | 57.3 | 59.0 |
| Concord Drugs Limited | 7.99 | -71.62 | 7.94 | 0.08 | 56 | 165.0 |
| BACIL PHARMA LTD. | NA | NA | NA | NA | 53.9 | 135.0 |
DIPNA PHARMACHEM LIMITED, with Security Code 543594, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Mar 2023 | Sep 2023 |
|---|---|---|---|
| Sales | 48.6 | 51.3 | 74.0 |
| Expenses | 47.7 | 49.9 | 72.5 |
| Operating Profit | 0.9 | 1.4 | 1.5 |
| OPM % | 1.86% | 2.8% | 2.06% |
| Other Income | 0.0 | 0.0 | 0.2 |
| Interest | 0.4 | 0.5 | 0.9 |
| Depreciation | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.5 | 0.9 | 0.8 |
| Tax % | -26.5% | -37.6% | -26.1% |
| Net Profit | 0.3 | 0.6 | 0.6 |
| EPS in Rs | 0.28 | 0.48 | 0.49 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 52% |
| 3 Years: | 74% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 105% |
| 3 Years: | 279% |
| TTM: | -30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 196% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|